Clinical Trials Update: Oct. 31, 2008
Neuropathy Acute Myelogenous Leukemia (AML) Multiple Sclerosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you have a diagnosis of orthostatic hypotension, you may be eligible for a new study.
The following conditions may be criteria for participation:
- Primary autonomic failure (Parkinson's disease, multiple system atrophy, pure autonomic failure)
- Dopamine beta hydroxylase deficiency
- Non-diabetic autonomic neuropathy
- A documented fall in systolic blood pressure or in diastolic blood pressure within 3 minutes of standing.
You must provide written informed consent to participate in the study.
The research site is in Birmingham, Ala.
Acute Myelogenous Leukemia (AML)
If you are at least 60 years old and have a diagnosis of previously untreated AML (either de novo or from an antecedent hematologic disorder or therapy-related AML), at least 20 percent blasts by BM biopsy, ECOG performance status of 0,1, or 2 and adequate cardiac, renal and liver function, you may be eligible to participate in this study.
The research site is in Beech Grove, Ind.
If you are between 18 and 80 years old, have a clinical diagnosis of pseudobulbar affect, exhibit involuntary episodes of laughing and/or crying and a confirmed diagnosis of amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS), you may be eligible to participate in this study.
The research site is in Las Vegas, Nev.
Copyright 2008 CenterWatch. All rights reserved.